Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …
Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced its plans to explore utilizing Molecular Envelope Technology (MET) for the intranasal delivery of a mRNA COVID vaccine. This innovative direction …
Virpax Pharmaceuticals Explores Intranasal mRNA Vaccine Delivery Using MET Read More
EXTON, PA — Innovative Solutions & Support (IS&S) (NASDAQ: ISSC) has announced that its Chief Executive Officer, Shahram Askarpour, and Chief Financial Officer, Jeffrey DiGiovanni, will participate in the Q1 …
Innovative Solutions & Support to Present at Q1 Investor Summit 2025 Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that findings from its dose range toxicity study for NES100, an innovative intranasal peptide for managing acute and chronic non-cancer pain, …
Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology Conference Read More
EXTON, PA — Dean W. Rivest, CEO of Omega Flex, Inc. (Nasdaq: OFLX), reported that the company’s net sales for 2024 totaled $101,681,000, compared to $111,465,000 in 2023, reflecting a …
Omega Flex Reports 2024 Financial Results: Sales and Income Decline Amid Market Challenges Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its fourth-quarter and full-year 2024 financial results, alongside significant progress across its clinical programs and regulatory initiatives. The company continues to drive …
Ocugen Reports 2024 Financial Results and Advances Gene Therapy Programs Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its 2024 financial results, detailing significant operational progress and strategic milestones, including the acquisition of Greenbrook TMS, FDA clearance for adolescent …
Neuronetics Reports 2024 Financial Results and Strategic Advances Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced its participation in two scheduled healthcare conferences in March 2025, where the company’s leadership team will provide insights into its …
Aclaris Therapeutics to Participate in Upcoming Healthcare Conferences Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the issuance of inducement awards in the form of Restricted Stock Units (RSUs) to three recently hired non-executive employees. These awards, …
Neuronetics Grants Inducement Awards to New Employees Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the European Commission has granted Advanced Therapy Medicinal Product (ATMP) classifications for its gene therapies OCU410 and OCU410ST. This regulatory milestone …
Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss Read More